Tetraphase Pharmaceuticals Balance Sheet - Quarterly (NASDAQ:TTPH)

Add to My Stocks
$2.9 $0.16 (5.23%) TTPH stock closing price Sep 18, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Tetraphase Pharmaceuticals balance sheet. Financial strength can be guaged by performing Tetraphase Pharmaceuticals stock analysis and by analyzing the balance sheet. Quarterly results are typically accompanied with the company releasing financial statements. Tetraphase Pharmaceuticals balance sheet as at the end of 2018 Q2 indicates an asset turnover ratio of 0.37 and debt to equity ratio of 0. Also check Tetraphase Pharmaceuticals revenue and Tetraphase Pharmaceuticals operating cash flow for the same period.

View and download Tetraphase Pharmaceuticals quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets6.03M6.93M6.38M5.49M5.11M3.82M6.58M6.69M5.25M7.04M
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable2.12M3.59M5.3M8.89M6.91M3.59M2.55M3.62M2.54M1.49M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses8.74M6.12M12.55M12.88M12.12M11.77M7.68M6.21M6.6M7.37M
Income Taxes Payable----------
Other Current Liabilities-7.47M--1.54M-1.25M1.07M1.19M1.37M
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus603.68M595.44M592.24M587.72M515.37M495.54M487.14M484.19M480.77M477.86M
Retained Earnings-493M-483.46M-461.88M-438.4M-408.4M-376.59M-347.13M-324.67M-303.56M-286.39M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity110.73M112.03M130.41M149.36M107.01M118.99M140.05M159.55M177.24M191.5M
Total Liabilities & Shareholders Equity121.79M129.37M149.04M172.04M127.74M135.35M151.71M170.64M187.73M201.89M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Tetraphase Pharmaceuticals stock price by looking at Tetraphase Pharmaceuticals historical stock prices. One can compare PE with industry average by looking at the Tetraphase Pharmaceuticals PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Tetraphase Pharmaceuticals owns and has monetary significance. TTPH assets decreased from $129.37M in 2018 Q1 to $121.79M in 2018 Q2. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. TTPH stock had total liabilities of $11.06M for the quarter 2018 Q2.

Tetraphase Pharmaceuticals Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio